{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:37:54Z","timestamp":1785267474539,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2016A030310193"],"award-info":[{"award-number":["2016A030310193"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.biopha.2019.109175","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T17:51:38Z","timestamp":1563990698000},"page":"109175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Salidroside and FG-4592 ameliorate high glucose-induced glomerular endothelial cells injury via HIF upregulation"],"prefix":"10.1016","volume":"118","author":[{"given":"Rui-yan","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-ling","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-bin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-ze","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamze","family":"Ibrahim Rage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-lan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-xia","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2019.109175_bib0005","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cnur.2018.07.006","article-title":"Clinical management of glomerular diseases","volume":"53","author":"Orr","year":"2018","journal-title":"Nurs. Clin. North Am."},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2019.109175_bib0010","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.diabres.2008.09.042","article-title":"Diabetic nephropathy: important pathophysiologic mechanisms","volume":"82","author":"Soldatos","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.biopha.2019.109175_bib0015","doi-asserted-by":"crossref","first-page":"F287","DOI":"10.1152\/ajprenal.00533.2014","article-title":"Glomerular endothelial cell injury and cross talk in diabetic kidney disease","volume":"308","author":"Fu","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.biopha.2019.109175_bib0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fphys.2017.00385","article-title":"Renal oxygenation in the pathophysiology of chronic kidney disease","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2019.109175_bib0025","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nrneph.2014.177","article-title":"Diabetic nephropathy: HIF activation in prevention of diabetic nephropathy","volume":"10","author":"Allison","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.biopha.2019.109175_bib0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrm1366","article-title":"Oxygen sensing by HIF hydroxylases","volume":"5","author":"Schofield","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2019.109175_bib0035","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/ki.2013.74","article-title":"Diabetic nephropathy: are there new and potentially promising therapies targeting oxygen biology?","volume":"84","author":"Miyata","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2019.109175_bib0040","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1021\/acs.jmedchem.7b01686","article-title":"Prolyl hydroxylase inhibitors: a breakthrough in the therapy of Anemia associated with chronic diseases","volume":"61","author":"Joharapurkar","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2019.109175_bib0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/13543784.2018.1417386","article-title":"Roxadustat in the treatment of anaemia in chronic kidney disease","volume":"27","author":"Del Vecchio","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.biopha.2019.109175_bib0050","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.biopha.2016.12.132","article-title":"Golden root: a wholesome treat of immunity","volume":"87","author":"Khanna","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2019.109175_bib0055","doi-asserted-by":"crossref","first-page":"E225","DOI":"10.1152\/ajpendo.00391.2015","article-title":"A novel mechanism of action for salidroside to alleviate diabetic albuminuria: effects on albumin transcytosis across glomerular endothelial cells","volume":"310","author":"Wu","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2019.109175_bib0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cbi.2017.10.012","article-title":"Salidroside alleviates high glucose-induced oxidative stress and extracellular matrix accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3 inflammasome pathway","volume":"278","author":"Wang","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biopha.2019.109175_bib0065","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.12659\/MSM.902806","article-title":"Salidroside reduces high-glucose-Induced podocyte apoptosis and oxidative stress via upregulating heme Oxygenase-1 (HO-1) expression","volume":"23","author":"Lu","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.biopha.2019.109175_bib0070","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/cam.29026","article-title":"Endothelial permeability and VE-cadherin: a wacky comradeship","volume":"8","author":"Gavard","year":"2014","journal-title":"Cell Adh. Migr."},{"key":"10.1016\/j.biopha.2019.109175_bib0075","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1021\/acs.jmedchem.8b00549","article-title":"Click chemistry-based discovery of [3-Hydroxy-5-(1 H-1,2,3-triazol-4-yl)picolinoyl]glycines as orally active hypoxia-inducing factor prolyl hydroxylase inhibitors with favorable safety profiles for the treatment of Anemia","volume":"61","author":"Wu","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2019.109175_bib0080","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.biopha.2018.07.157","article-title":"Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity","volume":"107","author":"Giri","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2019.109175_bib0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11255-017-1733-5","article-title":"Allopurinol protects human glomerular endothelial cells from high glucose-induced reactive oxygen species generation, p53 overexpression and endothelial dysfunction","volume":"50","author":"Eleftheriadis","year":"2018","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.biopha.2019.109175_bib0090","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00125-012-2469-5","article-title":"Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db\/db mice as a model of type 2 diabetes","volume":"55","author":"Persson","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2019.109175_bib0095","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrneph.2010.124","article-title":"The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease","volume":"6","author":"Mimura","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.biopha.2019.109175_bib0100","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1440-1681.2006.04476.x","article-title":"Intrarenal oxygenation in chronic renal failure","volume":"33","author":"Norman","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.biopha.2019.109175_bib0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3233\/NHA-170022","article-title":"A central role for hypoxia-inducible factor (HIF)-2alpha in hepatic glucose homeostasis","volume":"4","author":"Ramakrishnan","year":"2017","journal-title":"Nutr. Healthy Aging"},{"key":"10.1016\/j.biopha.2019.109175_bib0110","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1681\/ASN.2013090990","article-title":"Activation of hypoxia-inducible factors prevents diabetic nephropathy","volume":"26","author":"Nordquist","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2019.109175_bib0115","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2337\/db15-0519","article-title":"HIF-1 mediates renal fibrosis in OVE26 type 1 diabetic mice","volume":"65","author":"Nayak","year":"2016","journal-title":"Diabetes."},{"key":"10.1016\/j.biopha.2019.109175_bib0120","doi-asserted-by":"crossref","first-page":"21603","DOI":"10.1074\/jbc.M115.651604","article-title":"High glucose up-regulates ADAM17 through HIF-1alpha in mesangial cells","volume":"290","author":"Li","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2019.109175_bib0125","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1681\/ASN.2005090918","article-title":"High glucose blunts vascular endothelial growth factor response to hypoxia via the oxidative stress-regulated hypoxia-inducible factor\/hypoxia-responsible element pathway","volume":"17","author":"Katavetin","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2019.109175_bib0130","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2337\/db10-0655","article-title":"Tubular injury in a rat model of type 2 diabetes is prevented by metformin: a possible role of HIF-1alpha expression and oxygen metabolism","volume":"60","author":"Takiyama","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2019.109175_bib0135","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.exer.2011.06.003","article-title":"Increase in retinal hypoxia-inducible factor-2alpha, but not hypoxia, early in the progression of diabetes in the rat","volume":"93","author":"Wright","year":"2011","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2019.109175_bib0140","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.2014040350","article-title":"Vascular endothelial growth Factor-A165b is protective and restores endothelial glycocalyx in diabetic nephropathy","volume":"26","author":"Oltean","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2019.109175_bib0145","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3109\/0886022X.2013.773836","article-title":"The renal endothelium in diabetic nephropathy","volume":"35","author":"Eleftheriadis","year":"2013","journal-title":"Ren. Fail."},{"key":"10.1016\/j.biopha.2019.109175_bib0150","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMoa073123","article-title":"A gain-of-function mutation in the HIF2A gene in familial erythrocytosis","volume":"358","author":"Percy","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2019.109175_bib0155","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.2147\/DDDT.S175887","article-title":"The role of hypoxia-inducible factor stabilizers in the treatment of anemia in patients with chronic kidney disease","volume":"12","author":"Zhong","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.biopha.2019.109175_bib0160","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1042\/CS20171625","article-title":"Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury","volume":"132","author":"Yang","year":"2018","journal-title":"Clin. Sci."},{"key":"10.1016\/j.biopha.2019.109175_bib0165","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MNH.0000000000000341","article-title":"Hypoxia-inducible factor activation in diabetic kidney disease","volume":"26","author":"Persson","year":"2017","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.biopha.2019.109175_bib0170","first-page":"3658","article-title":"Deficiency of hypoxia inducible factor-1alpha promoted progression of diabetic nephropathy with hypertension","volume":"16","author":"Jiao","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2019.109175_bib0175","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3389\/fphys.2018.00865","article-title":"Pena E. Reactive oxygen species and pulmonary vasculature during hypobaric hypoxia","volume":"9","author":"Siques","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2019.109175_bib0180","first-page":"2977","article-title":"The role of hypoxia-inducible factors in carotid body (patho) physiology","volume":"596","author":"Semenza","year":"2018","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.biopha.2019.109175_bib0185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3892\/etm.2017.4541","article-title":"Salidroside inhibits high-glucose induced proliferation of vascular smooth muscle cells via inhibiting mitochondrial fission and oxidative stress","volume":"14","author":"Zhuang","year":"2017","journal-title":"Exp. Ther. Med."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219318773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219318773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:07:35Z","timestamp":1776427655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219318773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":37,"alternative-id":["S0753332219318773"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109175","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salidroside and FG-4592 ameliorate high glucose-induced glomerular endothelial cells injury via HIF upregulation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109175"}}